TNF

No data found

Search TNF biology news at Google

Search TNF biology news at Yahoo

Search TNF biology news at Msn

TNF at Biology Products

Equine TNF alpha ELISA development Kit, Screening Set from Endogen

Description:Endogens Screening Sets contain the basic components and protocol required to develop five colorimetric sandwich ELISA plates for quantitation of a specific protein in 100 l/well of cell culture supernate. Every Screening Set contains Coating and Detection Antibodies, Recombinant Standard (5 individual standards), Streptavidin-HRP, TMB Substrate Solution (one-step) and Stop Solution. Each standar...
Company:Endogen

Goat Anti-TNFalpha-IP 2 (G-17) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.

Description:TNFalpha-IP 2 (G-17)...
Company:Santa Cruz Biotechnology, Inc.

Equine TNF-alpha (TNFSF1A) ELISA development Kit, DuoSet from R&D Systems

Description:...
Company:R&D Systems

Rabbit Anti-sTNF-receptor I Polyclonal Antibody, Unconjugated from BioVision

Description:sTNF-receptor I Polyclonal Antibody 100 ug affinity purified rabbit anti-human sTNF-receptor I polyclonal antibody. Performs well in WB/Elisa/Neutralization....
Company:BioVision

Goat Anti-TNF-R2 (L-20) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.

Description:TNF-R2 (L-20)...
Company:Santa Cruz Biotechnology, Inc.

More>>

TNF at Biology Technology

No data found

Search TNF biology technology at Google

Search TNF biology technology at Yahoo

Search TNF biology technology at Msn

TNF at Medicine News

TNF Protein Can Predict GVHD Bone Marrow Transplant Recipients

The outcome of bone marrow transplant could be determined in just one week by measuring levels of a protein called tumor necrosis factor (TNF). // The inflammatory marker can help doctors identify which patients will develop graft vs. host disease (GVHD), the most commonly observed complication following the surgery. The early identification of related complication can enable the atte...

TNF Helps in the Understanding of the Immune System and Development of Drugs against Various Ills

Johns Hopkins researchers studied the activity and the major role played by the tumor necrosis factor (TNF) molecule in the activation of the immune system to combat infections. TNF is a common protein which delivers warning// message to cells in case of an invasion by a bacteria or virus. Then the TNF activates the body's immune system to fight the infection. The researcher said that fur...

Effects Of Age-related Vascular Diseases Can Be Reduced By Inactivating TNFa

A new study investigating the potential beneficial effects of TNFa inhibition in vascular aging//, "Vasculoprotective effects of anti-TNFa treatment in aging," appears in the January issue of The American Journal of Pathology. This study shows hope for significantly reducing vascular aging by inactivating TNFa, which has been linked to blood vessel dysfunction and cell death....

Does Anti-TNF Therapy Control Ankylosis ?

Arthritis is a condition resulting from inflammation of joints. It causes swelling and pain resulting in limited movement.// Spondylarthritis (SpA), ankylosing spondylitis (AS), psoriatic arthritis (PsA), and inflammatory bowel disease are all associated rheumatic diseases collectively known as "spondyloarthropathies".Aside from chronic inflammation, these conditions are all chara...

TNF at Medicine Products

No data found

Search TNF medicine products at Google

Search TNF medicine products at Yahoo

Search TNF medicine products at Msn

TNF at Medicine Technology

Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid Arthritis Study

Golimumab Demonstrated Sustained Improvement in Signs andSymptoms Of Moderate to Severe Rheumatoid Arthritis With One-Thirdof Patients Achieving Disease Remission at One-YearMark BARCELONA, Spain, 14 June 2007 – One-year data show nearly75 percent of patients with moderate to severe rheumatoid arthritis(RA) receiving golimumab (CNTO 148) and methotrexate (MTX)experienced a...

GenVec Announces Update of Safety and Efficacy Data from Pivotal Phase II/III PACT Study of TNFerade at ASCO

GAITHERSBURG, Md.--(BUSINESS WIRE)--Jun 4, 2007 - GenVec, Inc.(Nasdaq: GNVC) announced today that updated preliminary safety andefficacy data from the clinical development program of its leadproduct TNFerade(TM) was presented in a poster session ongastrointestinal cancers at the annual meeting of American Societyfor Clinical Oncology in Chicago, IL by Dr. Mitchell Posner, of theUniversity o...

Cytos Reports Results from Phase I/IIa Study with CYT007-TNFQb for the Treatment of Psoriasis

Schlieren (Zurich), Switzerland, May 24, 2007 - CytosBiotechnology AG (SWX:CYTN) reported today results from aplacebo-controlled, double-blind combined phase I/IIa study withCYT007-TNFQb, a novel vaccine candidate for the treatment ofpsoriasis and other inflammatory conditions. The present study wasa first-time-in-man clinical trial and included 48 patientssuffering from moderate to seve...

AGI Dermatics Data Shows the 8 Oxo-Guanine Repair Enzyme OGG1 Encapsulated in Liposomes, Reduces MMP-1 and TNF-alpha in UV Irradiated Skin Cells

Clinical Data Presented at the Society for InvestigativeDermatology FREEPORT, N.Y., May 16, 2007 /PRNewswire-FirstCall/ -- AGIDermatics today announced new clinical research that the8-oxo-guanine DNA glycosylase (OGG1) encapsulated in liposomesenhances DNA repair and reduces MMP-1 and TNF-alpha in UVirradiated skin cells. The data was presented at the 68th AnnualMeeting of the Society fo...

GenVec Announces New Research at AACR on Selectivity and Mechanism of Action of TNF-Based Anti-Cancer Therapy

GAITHERSBURG, Md.--(BUSINESS WIRE)--Apr 17, 2007 - GenVec, Inc.(Nasdaq:GNVC) announced today data from two studies presented atthe 97th annual meeting of the American Association of CancerResearch (AACR) that further support the use of adenovector systemsto deliver the gene for tumor necrosis factor-alpha (TNF(alpha)).GenVec's lead product candidate, TNFerade(TM) biologic (TNFerade)is an ad...